Akimitsu Hirai
Fondateur chez FUNPEP COMPANY LIMITED
Postes actifs de Akimitsu Hirai
Sociétés | Poste | Début | Fin |
---|---|---|---|
FUNPEP COMPANY LIMITED | Directeur/Membre du Conseil | 11/10/2013 | - |
Fondateur | 11/10/2013 | - | |
President | 11/10/2013 | - | |
Lexwell Partners | Fondateur | 01/04/1999 | - |
Corporate Officer/Principal | 01/04/1999 | - |
Historique de carrière de Akimitsu Hirai
Anciens postes connus de Akimitsu Hirai
Sociétés | Poste | Début | Fin |
---|---|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01/03/2013 | 01/12/2014 |
Directeur/Membre du Conseil | 01/12/2014 | - | |
Okinawa Protein Tomography Ltd.
Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Directeur/Membre du Conseil | 01/06/2014 | - |
RAQUALIA PHARMA INC. | Directeur/Membre du Conseil | 01/03/2010 | - |
Formation de Akimitsu Hirai
University of Washington | Graduate Degree |
Keio University | Graduate Degree |
Statistiques
Internationale
Japon | 7 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 4 |
Graduate Degree | 2 |
Founder | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
RAQUALIA PHARMA INC. | Health Technology |
FUNPEP COMPANY LIMITED | Health Technology |
Entreprise privées | 3 |
---|---|
Lexwell Partners | |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Okinawa Protein Tomography Ltd.
Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Commercial Services |
- Bourse
- Insiders
- Akimitsu Hirai
- Expérience